drugset / Trial / NCT04281004
Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-masked, placebo-controlled study to determine the safety of pAF in patients who undergo PRK.
Timeline
- Start
- 2020-07-10
- Primary completion
- 2023-01-16
- Completion
- 2023-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amniotic Fluid | Unknown | 0.25 ml | Other |
Indications
No indication recorded.